Epidemiological and clinical features of Moyamoya disease in Nanjing, China
- PMID: 20004511
- DOI: 10.1016/j.clineuro.2009.11.009
Epidemiological and clinical features of Moyamoya disease in Nanjing, China
Abstract
Objective: The epidemiology of Moyamoya disease in mainland China has not been documented. Therefore, the present study was designed to examine the epidemiological and clinical features of Moyamoya disease in Nanjing, a provincial capital in China.
Methods: Patient records from multiple hospitals in Nanjing from January 2000 to December 2007 were collected. The clinical features of Moyamoya disease were retrospectively analyzed.
Results: A total of 202 patients were identified. There were 94 males and 108 females, with ages ranging from 2 to 78 years. There was a dual age peak, one in the group of patients 5-9 years of age and another in the group of patients 35-39 years of age. The initial symptoms included cerebral ischemia (81 patients, 40%), cerebral hemorrhage (113 patients, 55.9%) and asymptomatic disease (8 patients, 3.9%). An increasing incidence rate of Moyamoya disease was observed during the period of 2000-2007, with an average detection rate of 0.43cases/100,000 persons/year (prevalence 3.92/100,000 persons). The incidence of ischemia associated with the disease was 0.16cases/100,000 people-years and the incidence of hemorrhage was 0.22cases/100,000 people-years.
Conclusion: This first study on the epidemiological and clinical features of Moyamoya disease in mainland China indicated an increasing incidence of Moyamoya disease with bimodal incidence distribution appearing more frequently in adults.
Similar articles
-
Epidemiological and clinical features of moyamoya disease in the USA.Neuroepidemiology. 2013;40(4):282-7. doi: 10.1159/000345957. Epub 2013 Feb 23. Neuroepidemiology. 2013. PMID: 23445954
-
The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease.Neurosurgery. 2008 Jan;62(1):104-11, discussion 111-2. doi: 10.1227/01.NEU.0000311067.41239.E6. Neurosurgery. 2008. PMID: 18300897
-
[Clinical significance of posterior cerebral artery stenosis/occlusion in moyamoya disease].No Shinkei Geka. 2002 Dec;30(12):1295-300. No Shinkei Geka. 2002. PMID: 12491581 Japanese.
-
Crohn's disease in mainland China: a systematic analysis of 50 years of research.Chin J Dig Dis. 2005;6(4):175-81. doi: 10.1111/j.1443-9573.2005.00227.x. Chin J Dig Dis. 2005. PMID: 16246226 Review.
-
Moyamoya disease: current concepts and future perspectives.Lancet Neurol. 2008 Nov;7(11):1056-66. doi: 10.1016/S1474-4422(08)70240-0. Lancet Neurol. 2008. PMID: 18940695 Review.
Cited by
-
Illness uncertainty, resilience, and perceived social support among patients with moyamoya disease: a cross-sectional study.Front Psychiatry. 2024 Jul 23;15:1405594. doi: 10.3389/fpsyt.2024.1405594. eCollection 2024. Front Psychiatry. 2024. PMID: 39109364 Free PMC article.
-
Multimodal neuronavigation-guided precision bypass in adult ischaemic patients with moyamoya disease: study protocol for a randomised controlled trial.BMJ Open. 2019 Mar 20;9(3):e025566. doi: 10.1136/bmjopen-2018-025566. BMJ Open. 2019. PMID: 30898819 Free PMC article.
-
Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease.Front Neurol. 2019 Jun 25;10:662. doi: 10.3389/fneur.2019.00662. eCollection 2019. Front Neurol. 2019. PMID: 31293503 Free PMC article.
-
Structural abnormalities in paediatric moyamoya disease revealed by clinical magnetic resonance imaging, regionally distributed relative signal intensities and volumes.Int J Dev Neurosci. 2022 Apr;82(2):146-158. doi: 10.1002/jdn.10167. Epub 2022 Jan 13. Int J Dev Neurosci. 2022. PMID: 34969179 Free PMC article.
-
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.Curr Neuropharmacol. 2022;20(2):292-308. doi: 10.2174/1570159X19666210716114016. Curr Neuropharmacol. 2022. PMID: 34279201 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources